Literature DB >> 20575153

Effectiveness of crosstrimester test in selecting high-risk pregnant women to undergo invasive prenatal diagnosis.

Paolo Guanciali-Franchi, Irene Iezzi, Barbara Matarrelli, Elisena Morizio, Giuseppe Calabrese, Giandomenico Palka.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20575153     DOI: 10.1002/pd.2539

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


× No keyword cloud information.
  5 in total

1.  A case of triploidy detected by crosstrimester test.

Authors:  Paolo Guanciali-Franchi; Irene Iezzi; Barbara Matarrelli; Elisena Morizio; Giuseppe Calabrese; Giandomenico Palka
Journal:  J Prenat Med       Date:  2012-07

Review 2.  First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

3.  Uncommon Presentation of Triploidy: A Case Report.

Authors:  Işil Uzun; Özlem Pata; Cihat Unlu; Fatma Tokat; Mucize Ozdemir
Journal:  J Clin Diagn Res       Date:  2015-10-01

Review 4.  Non-invasive prenatal screening: A 20-year experience in Italy.

Authors:  Chiara Palka; Paolo Guanciali-Franchi; Elisena Morizio; Melissa Alfonsi; Marco Papponetti; Giulia Sabbatinelli; Giandomenico Palka; Giuseppe Calabrese; Peter Benn
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2019-05-18

5.  Sequential combined test, second trimester maternal serum markers, and circulating fetal cells to select women for invasive prenatal diagnosis.

Authors:  Paolo Guanciali Franchi; Chiara Palka; Elisena Morizio; Giulia Sabbatinelli; Melissa Alfonsi; Donatella Fantasia; Giammaria Sitar; Peter Benn; Giuseppe Calabrese
Journal:  PLoS One       Date:  2017-12-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.